McGill Psychedelics Study: Depression Treatment Breakthrough | AcademicJobs
Explore McGill University's landmark 2026 study on psychedelics for depression, detailing brain changes and implications for Canadian higher education and therapy.
No reviews yet. Be the first to rate Danilo!
Danilo Bzdok serves as Associate Professor in the Department of Biomedical Engineering at McGill University’s Faculty of Medicine. He also holds the position of Canada CIFAR AI Chair at the Mila – Quebec Artificial Intelligence Institute. Bzdok maintains cross-appointments at the McConnell Brain Imaging Center, the Montreal Neurological Institute, the Ludmer Centre for Neuroinformatics and Mental Health, and the School of Computer Science at McGill University.
Bzdok trained at RWTH Aachen University in Germany, Université de Lausanne in Switzerland, and Harvard University in the United States. He completed a Ph.D. in cognitive neuroscience at the Research Center Juelich in Germany and a Ph.D. in computer science focused on machine learning statistics at INRIA Saclay and Neurospin in France. His research centers on narrowing knowledge gaps in the brain basis of human-defining types of thinking, with a special focus on the higher association cortex in health and disease, through data-guided analysis techniques applied to large neuroscience datasets.
Explore McGill University's landmark 2026 study on psychedelics for depression, detailing brain changes and implications for Canadian higher education and therapy.
McGill University's latest research uncovers five chronotype subtypes with unique health risks, reshaping sleep science for students and academics.
McGill University's latest research uncovers five chronotype subtypes linking brain patterns to sleep, health, and behaviors amid pandemic telework rise in Canadian higher education.